Caregiver Enhanced Assistance and Support for the Elderly Heart Failure Patient at Hospital Discharge (CEASE-HF)
Launched by MCMASTER UNIVERSITY · Jun 25, 2013
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Primary diagnosis of Heart Failure (with preserved or impaired left ventricular systolic dysfunction) confirmed with the Boston Criteria \>= 5 points
- • 60 years of age or older
- Exclusion Criteria:
- • Residence in, or planned discharge to a long-term care facility (LTC)
- • Life expectancy less than 3 months
- • Patient transferred to Geriatric Rehabilitation unit
- • No caregiver
- • Residence is more than a 30 minute rive from hospital of discharge
- • Patient refused to participate
- • Caregiver refused to participate
- • Patient referred for CV surgery prior to hospital discharge
- • Patient on IV Lasix at or bumetamide at hospital discharge
- • Not on PO Lasix at hospital discharge
- • Patient currently on dialysis
- • Caregiver unavailable during daytime hours
- • Caregiver has disability, serious mental illness or cognitive dysfunction
- • Patient discharged early
- • Patient enrolled in another randomized controlled trial
- • Patient expired
- • Patient and caregiver unable to speak and read English (Patient may be enrolled if nurse can converse minimally with patient and caregiver. S-TOFHLA will not be done for reading comprehension and questionnaires will be administered orally.)
- • Severe aortic stenosis or severe mitral stenosis
About Mcmaster University
McMaster University, a leading research institution located in Hamilton, Ontario, Canada, is renowned for its innovative approach to education and its commitment to advancing healthcare through rigorous clinical research. The university's diverse research programs are supported by a multidisciplinary team of experts dedicated to improving patient outcomes and public health. With a strong emphasis on evidence-based medicine, McMaster University actively engages in clinical trials that explore new therapies, interventions, and health technologies, fostering collaboration among researchers, healthcare professionals, and industry partners to translate findings into real-world applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hamilton, Ontario, Canada
Hamilton, Ontario, Canada
Patients applied
Trial Officials
Catherine Demers, MD, MSc, FRCPC
Principal Investigator
McMaster University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials